$MJNA Medical Marijuana I (MJNA) 0.3110 -0.0020 (-0.64%)
$MJNA
Medical Marijuana I (MJNA)
0.3110 -0.0020 (-0.64%)
Past 5 Days
Date Open High Low Last Change % Change Volume
03/21/14 0.3230 0.3250 0.3100 0.3110 -0.0020 -0.64% 3,043,145
03/20/14 0.3255 0.3260 0.3100 0.3130 -0.0130 -3.99% 9,188,300
03/19/14 0.3150 0.3390 0.3080 0.3260 +0.0120 +3.82% 11,904,000
03/18/14 0.3225 0.3265 0.3090 0.3140 -0.0066 -2.06% 8,934,899
03/17/14 0.3322 0.3345 0.3200 0.3206 -0.0094 -2.85% 12,280,000
Historical Highs and Lows
-- Period -- -- High -- -- Low -- -- Percent Change --
5-Day 0.3390 on 03/19/14 0.3080 on 03/19/14 -5.76% since 03/14/14
1-Month 0.3500 on 03/12/14 0.2850 on 03/05/14 +4.36% since 02/21/14
3-Month 0.4790 on 01/28/14 0.1000 on 12/26/13 +210.07% since 12/20/13
6-Month 0.4790 on 01/28/14 0.0850 on 11/26/13 +99.10% since 09/20/13
12-Month 0.4790 on 01/28/14 0.0160 on 08/13/13 +3.63% since 03/21/13
Year to Date 0.4790 on 01/28/14 0.1375 on 01/03/14 +100.65% since 12/31/13
New Highs and Lows
For The Last Made New High Percent From Made New Low Percent From
5-Day 2 times -8.26% 3 times +0.97%
1-Month 6 times -11.14% 3 times +9.12%
3-Month 8 times -35.07% 3 times +211.00%
6-Month 8 times -35.07% 15 times +265.88%
12-Month 4 times -35.07% 20 times +1,843.75%
Year to Date 3 times -35.07% 2 times +126.18%
Scroll down for more posts ▼
Top 10 Most Recent News Articles
When cancer pays an unwelcome visit to a family, it doesn’t come alone. It drags along fear, uncertainty, and bruising challenges. And as support needs balloon, thankfully there's a beacon like the Brian & Patricia Giese Foundation stepping up to sustain vital programs. Understanding the Real Impact Now, listen up. Cancer may target one body, but its claws reach...
Continue Reading
An Experienced Executor at the Helm Now, here's a story that rings of continuity meeting change. McGinnis Lochridge, a staple of the Texas legal scene since 1927, has tapped Charles Gillis to take charge as their Chief Operating Officer. You'd think they're gearing up to celebrate a hundred years by shaking things up internally. Why not bring in someone seasoned, I say?...
Continue Reading
InfraMed's Bold Move in Healthcare Real Estate You know, it’s not every day you see a company go all in on healthcare properties like InfraMed’s doing. With the blitz of new personnel, we're talking about a genuine push to carve out a piece of the national market. And if you've been keeping tabs, this isn't just a hunch—they've got serious momentum brewing, and the...
Continue Reading
Making Waves in Roofing: Roofr's Big Moves Listen up, folks. When a company like Roofr announces new tech, contractors better pay attention. The roofing industry—often overlooked by the flashy tech scene—just got hit with some slick new tools. Today, Roofr held its semi-annual virtual event, Roofr Builds, unraveling a slew of updates that might just streamline the way...
Continue Reading
Details on Escalade's Upcoming Financial Revelation Evansville's own Escalade, Inc. (NASDAQ: ESCA) is set to drop its third quarter 2026 financial results on October 29, well before your breakfast is done. For anyone following this stock, it's like waiting for the last few seconds of a tied basketball game. This isn’t just about numbers – it’s about a whole host of...
Continue Reading
There's a fresh breeze blowing through the building industry, and it's got "net zero" written all over it. Green Builder Media is rolling out a pile of new resources aimed at wrangling this beast of a trend. The focus? High-performance, all-electric homes. And they're not just whispering about it—they've got hard data and practical guidance to back up their claims. Net...
Continue Reading
What’s Orangetheory Up To Now? Ah, fitness gadgets, where everyone’s seemingly got a scheme brewing. This time it's Orangetheory (OTF), turning your Apple Watch into your new best gym buddy. October 22, 2026, marks the launch of OTconnect for Apple Watch, offering a slick way for enthusiasts to tune into their own sweat metrics. If you’re already an Apple Watch...
Continue Reading
New Era for Myeloma Research In a move set to shake up the oncology world, the International Myeloma Foundation (IMF) is lighting a fire under clinical research with its ambitious US Myeloma Network (USMN). The whole shebang is about supercharging clinical trials and bringing real hope to folks battling multiple myeloma. If you've been watching the space, you know we're...
Continue Reading
A Shift Toward Nature-Driven Choices There's something brewing in the fashion world that signals a deeper shift—a movement toward fibers that feel real, fibers that nature and time have refined. Recent Ipsos research commissioned by Woolmark has laid bare the growing consumer preference across major markets, with a distinct swing towards natural fibers, leaving...
Continue Reading
Fort Point Capital's Strategic Play Just when you thought the game was getting stale, Fort Point Capital dropped a bomb: they’ve sold AMS Fulfillment to Stord. This isn't just some late-season punt; it's a calculated play from a Boston-based private equity player known for snapping up and scaling service-oriented businesses in the lower middle market. It's like...
Continue Reading
Top 5 Most Recently Viewed Articles
Enhancing Interoperability and Collaboration in Healthcare In an era where seamless integration is crucial, Secure Exchange Solutions (SES) emerges as a key player in the healthcare landscape. SES is part of Centauri Health Solutions, specializing in cloud-based clinical data exchange, and is dedicated to improving connectivity among healthcare providers. With its...
Continue Reading
Paris Baguette Reaches a Milestone with 200th Cafe The celebrated bakery café brand, Paris Baguette, has officially opened its 200th cafe in North America, marking a tremendous achievement. With a strong commitment to serving communities, this milestone demonstrates the brand's ambition to provide freshly baked goods throughout the U.S. and Canada. Celebrating the 200th...
Continue Reading
Navigating Economic Changes: A New Investment Landscape In recent times, shifts in economic policies have spurred conversations about potential revamps in the U.S. economy. The implementation of tariffs has emerged as a significant strategy aimed at revitalizing domestic manufacturing. This economic reset aims to strengthen national security while boosting local...
Continue Reading
Overview of Ascentage Pharma's Interim Results Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) recently announced its interim unaudited financial results for the first half of 2025. The report highlights significant growth, particularly in product sales, and provides exciting updates on ongoing clinical programs and commercial strategies. The company's...
Continue Reading
Parsons Corporation Wins $4 Billion Defense Contract Parsons Corporation has proudly announced that it has been awarded an indefinite-delivery, indefinite-quantity (IDIQ) multiple award task order contract (MATOC) by the Defense Threat Reduction Agency (DTRA). The lucrative contract has a ceiling value of $4 billion and is aimed at supporting Countering Weapons Of Mass...
Continue Reading